<DOC>
	<DOC>NCT01417312</DOC>
	<brief_summary>This study aims to investigate metabolic effects of a standardized green tea extract, containing a defined amount of epigallocatechin-3-gallate (EGCG), in multiple sclerosis patients.</brief_summary>
	<brief_title>Metabolic Effects of a Green Tea Extract in Multiple Sclerosis Patients</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis, Relapsing-Remitting</mesh_term>
	<criteria>Patients with relapsingremitting multiple sclerosis stable treatment with glatiramer acetate at least 6 months prior to inclusion Expanded disability status scale &lt; 4.5 Normal weight, overweight Primary or secondary progressive forms of multiple sclerosis Clinically relevant heart, lung, liver, kidney diseases Habitual caffeine intake over 300 mg per day Habitual consumption of green tea Alcohol or drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Multiple sclerosis</keyword>
	<keyword>Green tea extract</keyword>
	<keyword>Metabolism</keyword>
</DOC>